Duality Biotherapeutics, Inc.
Research Duality Biotherapeutics, Inc. (4ZB) on Bullrun: market cap EUR 1.68B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4ZB
- ExchangeF
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 1.68B
- Financial periodQ4 2024
- RevenueEUR 479.25M
- Net income-EUR 483.95M
- Free cash flowEUR 255.30M
- Gross margin26.1%
Valuation Snapshot
latest market cap is EUR 1.68B.
About Duality Biotherapeutics, Inc.
Duality Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others in China and internationally. The company provides DB-1303/BNT323, a HER2 ADC candidate targeting cancers, including endometrial cancer1 and breast cancer2;
Frequently asked questions
What is Duality Biotherapeutics, Inc.'s market cap?
Duality Biotherapeutics, Inc.'s market capitalization is EUR 1.68B.
What does Duality Biotherapeutics, Inc. do?
Duality Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others in China and internationally.